Impact of the COVID-19 Pandemic on Surgical Oncology in Europe: Results of a European Survey
| Autor: | Alexander Novotny, Ilaria Pergolini, Daniel Hartmann, Helmut Friess, Christian Stöss, Marcella Steffani, Dejan Radenkovic, Michael W. Müller |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty 2019-20 coronavirus outbreak Operating Rooms Coronavirus disease 2019 (COVID-19) Hospital bed Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic Time-to-Treatment 03 medical and health sciences 0302 clinical medicine Surgical oncology Neoplasms Oncology Service Hospital Surveys and Questionnaires Pandemic medicine Ambulatory Care Outpatient clinic Humans 030304 developmental biology 0303 health sciences Surgical care business.industry General surgery Digestive surgery Gastroenterology COVID-19 Middle Aged European surgery 3. Good health Europe Survival Rate Cross-Sectional Studies Surgical Oncology Chemotherapy Adjuvant Hospital Bed Capacity 030220 oncology & carcinogenesis Surgery Female business Research Article |
| Zdroj: | Digestive Surgery |
| ISSN: | 1421-9883 0253-4886 |
| Popis: | Background: The first COVID-19 pandemic wave hit most of the health-care systems worldwide. The present survey aimed to provide a European overview on the COVID-19 impact on surgical oncology. Methods: This anonymous online survey was accessible from April 24 to May 11, 2020, for surgeons (n = 298) who were contacted by the surgical society European Digestive Surgery. The survey was completed by 88 surgeons (29.2%) from 69 different departments. The responses per department were evaluated. Results: Of the departments, 88.4% (n = 61/69) reported a lower volume of patients in the outpatient clinic; 69.1% (n = 47/68) and 75.0% (n = 51/68) reported a reduction in hospital bed and the operating room capacity, respectively. As a result, the participants reported an average reduction of 29.3% for all types of oncological resections surveyed in this questionnaire. The strongest reduction was observed for oncological resections of hepato-pancreatico-biliary (HPB) cancers. Of the interviewed surgeons, 68.7% (n = 46/67) agreed that survival outcomes will be negatively impacted by the pandemic. Conclusion: The first COVID-19 pandemic wave had a significant impact on surgical oncology in Europe. The surveyed surgeons expect an increase in the number of unresectable cancers as well as poorer survival outcomes due to cancellations of follow-ups and postponements of surgeries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|